glycerol at 4°C overnight, the cells were incubated for 1 h at 4 °C with rabbit polyclonal anti-FLAG antibody (1:1000) and mouse monoclonal anti-HA antibody. Reacting antibodies were stained with fluorescein-conjugated goat anti-rabbit IgG and rhodamine-conjugated goat anti-mouse IgG 2b (Santa Cruz). Fluorescence microscopy of fixed cells was performed using an Olympus BX-50 confocal laser scanning microscope.
Generation of Elongin A-deficient mice.
Elongin A-deficient mice were generated as previously described [15] . Briefly, Elongin A mutant ES cell clones were microinjected into blastocysts for the generation of chimeric mice. Chimeric males were crossed with C57BL/6 females, and agouti-colored offspring were analyzed for the germline transmission of the Elongin A mutation. Heterozygous animals were intercrossed to generate homozygous mutant animals.
PCR genotyping. Genomic DNA was isolated from embryonic yolk sacs, and genotyping was performed using PCR as described [15] .
Preparation of MEFs.
MEFs were prepared from E10.5 embryos as described [15] .
Briefly, fetal tissue samples were rinsed in PBS and then were mechanically dissociated in DMEM with 10% FBS. The cells were then plated out on 6-well plates. These cells were considered to be passage 1 MEFs.
Quantitative analysis of apoptosis in MEFs.
For the quantitative analysis and to determine the cytoplasmic histone-associated DNA fragments, which are indicative of on-going apoptosis, the Cell Death Detection ELISA PLUS (Roche Applied Science) was used according to the manufacturer's instructions.
Replication labeling. Cells were labeled with biotin-16-dUTP and digoxigenin-11-dUTP (Roche Applied Science) at 20-min or 30-min intervals using hypotonic shift procedure with slight modifications [19] . Cells grown on a 35-mm-diameter dish were washed with 1 ml of KH buffer (30 mM KCl, 10 mM HEPES, pH 7.4) and then 10 µl of KH buffer supplemented with 250 µM biotin-16-dUTP or digoxigenin-11-dUTP (Roche Applied Science) was added. After incubation at 37˚C with 5% CO 2 for 10 min, the samples were washed with serum-free medium and cultured in normal medium for 20 min or 30 min to introduce modified nucleotides into nascent DNA. DNA fiber preparation was performed as described previously [20, 21] . Replication labeled cells and 10-to 20-fold unlabeled cells were mixed before sample preparation because DNA fibers were extended straight and each 
Results and discussion

Identification of the nuclear localization signals of Elongin A
We have previously shown that Elongin A and its related family proteins are predominantly localized in the cell nucleus [16, 18] . In this study, we analyzed the sequences of Elongin A required for its nuclear localization using immunostaining assays. COS7 cells were transfected with constructs expressing wild-type or various deletion mutants of Elongin A with FLAG-tag at their NH 2 -terminus, and stained with anti-FLAG antibody. As shown in Fig. 1 , the Elongin A mutant composed of residues 400-589 was clearly localized in the nucleus. Analysis of the amino acid sequences in this region of Elongin A indicated four short sequences rich in basic amino acids that resemble the potential nuclear localization signals (NLSs): amino acids 413 to 418 (NLS1; RKKKKK), 433 to 435 (NLS2; KKK), 470 to 473 (NLS3; RPRK), and 509 to 511 (NLS4; KRK) [22, 23] . In order to determine whether any of these sequences is functional, four additional deletion mutants that lacked either NLS1, NLS2, NLS3 or NLS4 from residues 400-589 of Elongin A were constructed. Transfection of COS7 cells with expression vectors containing these deletion mutants demonstrated that NLS1, but not NLS2, NLS3 or NLS4, was required for nuclear localization, as the encoded protein missing NLS1 was identified in the cytoplasm (Fig. 1B) . In contrast, the deletion of any of NLS2, NLS3 or NLS4 did not disrupt the nuclear localization of the encoded protein.
Identification of Elongin A region responsible for the direct interaction with pol II
In previous studies, we have demonstrated that Elongin A is capable of stimulating the rate of transcription elongation in vitro in the reaction mix containing only DNA template and pol II, and that the COOH terminus of Elongin A (residues 400-773) possesses a level of elongation stimulatory activity comparable to full-length Elongin A [8, 14] . From these findings, it was postulated that Elongin A interacts with pol II in a direct manner and that the amino acid sequences responsible for this interaction reside in residues 400-773 of Elongin A.
Thus, to confirm the above presumptions, various truncation mutants of Elongin A were fused to GST, expressed in E. coli, and immobilized on glutathione-sepharose resin. These resins were then incubated with purified pol II. After extensive washing, the bound protein was eluted, fractionated on an SDS-PAGE gel, and probed with 8WG16 antibody. As shown in Fig. 2 , pol II was retained by the GST-Elongin A(400-773) affinity resins, while no detectable pol II was retained by the resin containing GST-Elongin A(1-399). Subsequent analysis demonstrated that GST fused with residues 590-690 of Elongin A bound to pol II. Meanwhile, GST fused with residues 1-120 of Elongin A, which is 29% identical and 53% similar to the NH 2 -terminus of SII and has been shown to interact with pol II holoenzyme complex [24] , failed to bind to purified pol II.
Taken together, these results suggest: (i) residues 590-690 of Elongin A, which is the region highly conserved between Elongin A and its related family members, Elongins A2 and A3 [18] , are responsible for the direct interaction with pol II; and (ii) interaction of the NH 2 terminus of Elongin A with pol II seems to be indirect, and most likely mediated through some of the components of the pol II holoenzyme complex.
Induction of genomic instability in Elongin A -/-
MEFs
To gain more insight into the role of Elongin A in vivo, we have recently generated Inhibition of the elongation phase of transcription by various agents, such as UV light, camptothecin or actinomycin D, has also been reported to lead to the activation of p53 and the induction of apoptosis [25, 26] . The induction of apoptosis following elongation blockage has been shown to occur preferentially in the S phase of the cell cycle [27] . As transcription also persists during the S phase of the cell cycle [28] , it is possible that oncoming replication forks might occasionally collide with the blocked pol II elongation complexes, and that these collisions might lead to the stalling and breakdown of replication forks, resulting in genomic instability and the triggering of apoptosis. performed. Under our experimental conditions, mRNAs whose levels were decreased or increased by 2-fold or greater were considered to be differentially expressed transcripts.
The rate of replication fork movement is significantly reduced in Elongin
As shown in Table 1 , the expression of the genes whose translational products play important roles in regulating the process of DNA replication was either not or was only weakly altered in Elongin A -/-MEFs, suggesting that the deficiency of replication factors might not be the cause of the replication fork impairment in Elongin A -/-MEFs.
In addition, the expression levels of the pol II elongation factor-related genes, excluding Elongin A, did not significantly decrease.
In summary, we have carried out the structure-function analysis of transcription elongation factor Elongin A and identified sequences critical for its functionthat is, i) nuclear localization, and ii) interaction with pol II. In addition, we have analyzed the rate of replication fork movement in wild-type and Elongin A -/-possibility that the genomic instability observed in Elongin A -/-MEFs might be caused by the replication fork collapse due to the lack of Elongin A. Therefore, it seems reasonable to speculate that Elongin A in cells plays roles not only in quantitatively regulating the synthesis of mRNA but also in maintaining the genomic stability by preventing pausing or arrest of the transcribing pol II.
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